Recombinant Full-Length Hepatitis C Virus E1E2 Dimer Elicits Pangenotypic Neutralizing Antibodies
Authors:
Open Access
- 28 June 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 831285
Abstract
An effective prophylactic vaccine would be beneficial for controlling and eradicating hepatitis C virus (HCV) infections. However, the high diversity across HCV genotypes is a major challenge for vaccine development. Selection of the appropriate immunogen is critical to elicit broad HCV neutralizing antibodies (NAbs). To increase the antigenic coverage of heterodimer glycoproteins, we designed and produced recombinant E1E2 antigens for genotypes 1a/1b/2a/3a/6a from an IgG Fc-tagged precursor protein in FreeStyle 293-F cells. The recombinant E1 and E2 antigens were localized and associated with the endoplasmic reticulum and co-purified from membrane extracts. By examining the interactions with HCV entry co-receptors and the blockade of HCV infection, we found that these purified Fc-E1E2 proteins displayed correct folding and function. Mouse immunization results showed that each recombinant E1E2 antigen could elicit a pangenotypic antibody response to itself and other genotypes. We also found that the pentavalent formula triggered a relatively higher and more uniform NAb titer and T cell response than monovalent antigens. Taken together, our findings may provide a useful strategy for the vaccine development of HCV and other viruses with highly heterogeneous surface glycoproteins.Keywords
This publication has 48 references indexed in Scilit:
- A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in HumansPLOS ONE, 2013
- Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in ChimpanzeesPLOS Pathogens, 2012
- Hepatitis C Virus Induces CD81 and Claudin-1 EndocytosisJournal of Virology, 2012
- Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virusProceedings of the National Academy of Sciences, 2012
- Characterization of the Envelope Glycoproteins Associated with Infectious Hepatitis C VirusJournal of Virology, 2010
- Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope GlycoproteinsThe Journal of Infectious Diseases, 2010
- Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adultsVaccine, 2010
- Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C VirusScience Translational Medicine, 2010
- Correlation of the Tight Junction-like Distribution of Claudin-1 to the Cellular Tropism of Hepatitis C VirusJournal of Biological Chemistry, 2008
- High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-upBritish Journal of Cancer, 2006